Table 2.
The prevalence and distribution of genders in UU, CT, and NG positive patients in different genders and age groups.
| Age groups | Total | Male | Female | p | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Proportion (%) | PDR [95% CI] (%) | N | Proportion (%) | PDR [95% CI] (%) | N | Proportion (%) | PDR [95% CI] (%) | |||||
| UU | 4,887 | 100% | 30.14% | [29.44–30.85%] | 2,048 | 41.91% | 33.36% | [32.19–34.55%] | 2,839 | 58.09% | 28.18% | [27.31–29.07%] | <0.0001 |
| ≤ 20 | 77 | 1.58% | 40.53% | [33.80–47.63%] | 27 | 35.06% | 32.14% | [23.12–42.72%] | 50 | 64.94% | 47.17% | [37.93–56.60%] | 0.2200 |
| 21–30 | 2,052 | 41.99% | 32.66% | [31.51–33.83%] | 879 | 42.84% | 35.37% | [33.51–37.27%] | 1,173 | 57.16% | 30.88% | [29.43–32.37%] | 0.2627 |
| 31–40 | 1,952 | 39.94% | 27.87% | [26.83–28.93%] | 894 | 45.80% | 34.60% | [32.79–36.46%] | 1,058 | 54.20% | 23.93% | [22.7–25.21%] | <0.0001 |
| 41–50 | 544 | 11.13% | 31.83% | [29.66–34.08%] | 181 | 33.27% | 29.92% | [26.41–33.69%] | 363 | 66.73% | 32.88% | [30.17–35.71%] | <0.0001 |
| 51–60 | 191 | 3.91% | 30.91% | [27.39–34.66%] | 40 | 20.94% | 20.94% | [15.77–27.25%] | 151 | 79.06% | 35.36% | [30.97–40.01%] | <0.0001 |
| >60 | 71 | 1.45% | 17.27% | [13.92–21.22%] | 27 | 38.03% | 14.14% | [9.90–19.79%] | 44 | 61.97% | 20.00% | [15.25–25.78%] | 0.5046 |
| CT | 973 | 100% | 6.00% | [5.64–6.38%] | 513 | 52.72% | 8.36% | [7.69–9.08%] | 460 | 47.28% | 4.57% | [4.18–5.00%] | <0.0001 |
| ≤ 20 | 36 | 3.70% | 18.95% | [14.01–25.12%] | 17 | 47.22% | 20.24% | [13.04–30.04%] | 19 | 52.78% | 17.92% | [11.78–26.30%] | 0.5005 |
| 21–30 | 470 | 48.30% | 7.48% | [6.86–8.16%] | 238 | 50.64% | 9.58% | [8.48–10.80%] | 232 | 49.36% | 6.11% | [5.39–6.92%] | 0.2079 |
| 31–40 | 356 | 36.59% | 5.08% | [4.59–5.62%] | 191 | 53.65% | 7.39% | [6.44–8.46%] | 165 | 46.35% | 3.73% | [3.21–4.33%] | 0.6596 |
| 41–50 | 80 | 8.22% | 4.68% | [3.78–5.79%] | 50 | 62.50% | 8.26% | [6.32–10.73%] | 30 | 37.50% | 2.72% | [1.91–3.86%] | 0.0675 |
| 51–60 | 24 | 2.47% | 3.88% | [2.62–5.71%] | 12 | 50.00% | 6.28% | [3.63–10.66%] | 12 | 50.00% | 2.81% | [1.61–4.85%] | 0.7867 |
| >60 | 7 | 0.72% | 1.70% | [0.83–3.47%] | 5 | 71.43% | 2.62% | [1.12–5.98%] | 2 | 28.57% | 0.91% | [0.25–3.25%] | 0.5386 |
| NG | 340 | 100% | 2.10% | [1.89–2.33%] | 277 | 81.47% | 4.51% | [4.02–5.06%] | 63 | 18.53% | 0.63% | [0.49–0.80%] | <0.0001 |
| ≤ 20 | 32 | 9.41% | 16.84% | [12.19–22.81%] | 22 | 68.75% | 26.19% | [17.98–36.48%] | 10 | 31.25% | 9.43% | [5.20–16.5%] | 0.0517 |
| 21–30 | 147 | 43.24% | 2.34% | [1.99–2.74%] | 116 | 78.91% | 4.67% | [3.91–5.57%] | 31 | 21.09% | 0.82% | [0.58–1.18%] | 0.2892 |
| 31–40 | 114 | 33.53% | 1.63% | [1.36–1.95%] | 100 | 87.72% | 3.87% | [3.19–4.68%] | 14 | 12.28% | 0.32% | [0.19–0.54%] | 0.0352 |
| 41–50 | 29 | 8.53% | 1.70% | [1.19–2.43%] | 26 | 89.66% | 4.30% | [2.95–6.23%] | 3 | 10.34% | 0.27% | [0.09–0.79%] | 0.2356 |
| 51–60 | 15 | 4.41% | 2.43% | [1.48–3.97%] | 10 | 66.67% | 5.24% | [2.87–9.37%] | 5 | 33.33% | 1.17% | [0.50–2.71%] | 0.2422 |
| >60 | 3 | 0.88% | 0.73% | [0.25–2.12%] | 3 | 100% | 1.57% | [0.54–4.51%] | 0 | 0% | 0.00% | [0.00–1.72%] | 1.0000 |